11/12 UT and Epicur Pharma Lunch and Learn

Join us for an in-person Lunch and Learn CE event presented by Dr. David Rendle, RCVS and European Specialist in Equine Internal Medicine. Dr. Rendle will share the latest updates on managing equine squamous and glandular gastric disease, including how extended-release injectable omeprazole is being used in practice.

Updates on the Treatment of Equine Gastric Disease
Speaker: David Rendle, BVSc, MVM, CertEM(IntMed), DipECEIM, FRCVS, RCVS and European Specialist in Equine Internal Medicine

Description and learning objectives:
This lecture will highlight recent developments in the management of both squamous and glandular gastric disease, reviewing recent publications in the context of existing knowledge. Attendees gain an understanding of the limitations of oral proton pump inhibitors and explore advances in newer generation PPIs, including extended-release injectable omeprazole. The session also covered the published evidence supporting a range of treatment options for gastric disease.

Learning objectives:
Appreciate the limitations of oral proton pump inhibitors in the management of gastric disease
Understand recent developments in the use of newer generation proton pump inhibitors
Learn how extended release injectable omeprazole is being used in the management of gastric disease
Have an understanding of the published evidence for a range of treatments for gastric disease